Brief: Merck & Co., Inc. Says Has 5.4% Passive Stake In Xilio Therapeutics, Inc. As Of March 30, 2023 - SEC Filing
April 10 (Reuters) - Merck & Co Inc MRK.N :
* MERCK & CO., INC. SAYS HAS 5.4% PASSIVE STAKE IN XILIO
THERAPEUTICS, INC. AS OF MARCH 30, 2023 - SEC FILING
Source text for Eikon: ID:
Further company coverage: MRK.N
((Reuters.Brief@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla